Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 72

1.

Bendamustine: rebirth of an old drug.

Cheson BD, Rummel MJ.

J Clin Oncol. 2009 Mar 20;27(9):1492-501. doi: 10.1200/JCO.2008.18.7252. Epub 2009 Feb 17. Review. Erratum in: J Clin Oncol. 2009 Jun 10;27(17):2892.

PMID:
19224851
[PubMed - indexed for MEDLINE]
Free Article
2.

Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.

Dennie TW, Kolesar JM.

Clin Ther. 2009;31 Pt 2:2290-311. doi: 10.1016/j.clinthera.2009.11.031. Review.

PMID:
20110042
[PubMed - indexed for MEDLINE]
3.

Bendamustine for the treatment of indolent non-Hodgkin's lymphoma and chronic lymphocytic leukemia.

Elefante A, Czuczman MS.

Am J Health Syst Pharm. 2010 May 1;67(9):713-23. doi: 10.2146/ajhp090328. Review.

PMID:
20410545
[PubMed - indexed for MEDLINE]
4.

Bendamustine: a review of its use in the management of indolent non-Hodgkin's lymphoma and mantle cell lymphoma.

Garnock-Jones KP.

Drugs. 2010 Sep 10;70(13):1703-18. doi: 10.2165/11205860-000000000-00000. Review.

PMID:
20731477
[PubMed - indexed for MEDLINE]
5.

Bendamustine: a review of its use in the management of chronic lymphocytic leukaemia, rituximab-refractory indolent non-Hodgkin's lymphoma and multiple myeloma.

Hoy SM.

Drugs. 2012 Oct 1;72(14):1929-50. doi: 10.2165/11209510-000000000-00000. Review.

PMID:
22950536
[PubMed - indexed for MEDLINE]
6.

Bendamustine's emerging role in the management of lymphoid malignancies.

Rummel MJ, Gregory SA.

Semin Hematol. 2011 Apr;48 Suppl 1:S24-36. doi: 10.1053/j.seminhematol.2011.03.004. Review.

PMID:
21530769
[PubMed - indexed for MEDLINE]
7.

Bendamustine in the treatment of chronic lymphocytic leukemia.

Knauf W.

Expert Rev Anticancer Ther. 2009 Feb;9(2):165-74. doi: 10.1586/14737140.9.2.165. Review.

PMID:
19192955
[PubMed - indexed for MEDLINE]
8.

Bendamustine in the treatment of non-Hodgkin's lymphoma: results and future perspectives.

Rummel MJ, Mitrou PS, Hoelzer D.

Semin Oncol. 2002 Aug;29(4 Suppl 13):27-32. Review.

PMID:
12170430
[PubMed - indexed for MEDLINE]
9.

Bendamustine.

Balfour JA, Goa KL.

Drugs. 2001;61(5):631-8; discussion 639-40. Review.

PMID:
11368287
[PubMed - indexed for MEDLINE]
10.

Bendamustine: a new treatment option for chronic lymphocytic leukemia.

Glode AE, Jarkowski A.

Pharmacotherapy. 2009 Nov;29(11):1375-84. doi: 10.1592/phco.29.11.1375. Review.

PMID:
19857152
[PubMed - indexed for MEDLINE]
11.

Bendamustine in chronic lymphocytic leukemia and non-Hodgkin's lymphoma.

Ujjani C, Cheson BD.

Expert Rev Anticancer Ther. 2010 Sep;10(9):1353-65. doi: 10.1586/era.10.116. Review.

PMID:
20836669
[PubMed - indexed for MEDLINE]
12.

Bendamustine: something old, something new.

Tageja N, Nagi J.

Cancer Chemother Pharmacol. 2010 Aug;66(3):413-23. doi: 10.1007/s00280-010-1317-x. Epub 2010 Apr 8. Review.

PMID:
20376452
[PubMed - indexed for MEDLINE]
13.

Bendamustine: a new look at an old drug.

Kalaycio M.

Cancer. 2009 Feb 1;115(3):473-9. doi: 10.1002/cncr.24057. Review.

PMID:
19117340
[PubMed - indexed for MEDLINE]
Free Article
14.

Bendamustine: a review of its use in the management of indolent non-Hodgkin lymphoma.

Plosker GL, Carter NJ.

Drugs. 2008;68(18):2645-60. doi: 10.2165/0003495-200868180-00009. Review.

PMID:
19093705
[PubMed - indexed for MEDLINE]
15.

Bendamustine: rescue of an effective antineoplastic agent from the mid-twentieth century.

Leoni LM.

Semin Hematol. 2011 Apr;48 Suppl 1:S4-11. doi: 10.1053/j.seminhematol.2011.03.002. Review.

PMID:
21530771
[PubMed - indexed for MEDLINE]
16.

Bendamustine therapy in chronic lymphocytic leukemia.

Masiello D, Tulpule A.

Expert Opin Pharmacother. 2009 Jul;10(10):1687-98. doi: 10.1517/14656560903032698. Review.

PMID:
19527193
[PubMed - indexed for MEDLINE]
17.

Phase I studies with bendamustine: an update.

Schrijvers D, Vermorken JB.

Semin Oncol. 2002 Aug;29(4 Suppl 13):15-8. Review.

PMID:
12170427
[PubMed - indexed for MEDLINE]
18.

Bendamustine: new perspective for an old drug in lymphoproliferative disorders.

Montillo M, Ricci F, Tedeschi A, Vismara E, Morra E.

Expert Rev Hematol. 2010 Apr;3(2):131-48. doi: 10.1586/ehm.10.7. Review.

PMID:
21083456
[PubMed - indexed for MEDLINE]
19.

Optimal use of bendamustine in chronic lymphocytic leukemia, non-Hodgkin lymphomas, and multiple myeloma: treatment recommendations from an international consensus panel.

Cheson BD, Wendtner CM, Pieper A, Dreyling M, Friedberg J, Hoelzer D, Moreau P, Gribben J, Knop S, Montillo M, Rummel M.

Clin Lymphoma Myeloma Leuk. 2010 Feb;10(1):21-7. doi: 10.3816/CLML.2010.n.002. Review.

PMID:
20223726
[PubMed - indexed for MEDLINE]
20.

Metabolism and mechanisms of action of bendamustine: rationales for combination therapies.

Gandhi V.

Semin Oncol. 2002 Aug;29(4 Suppl 13):4-11. Review.

PMID:
12170425
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk